Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04031092
Other study ID # 2019/800
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 8, 2019
Est. completion date January 14, 2020

Study information

Verified date January 2020
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this project is to evaluate whether use of wearable tech increases levels of physical activity in patients participating in inpatient rehabilitation for chronic pain.


Description:

Chronic pain is a vast problem with profound consequences for individuals and societies. Exercise and physical activity is an important part of the treatment for chronic pain. Use of wearable tech might be a way to help facilitate physical activity in patients with chronic pain. Here it will be evaluated whether use of wearable tech giving feedback about the user`s activity level increases physical activity in patients participating in inpatient rehabilitation for chronic pain. The control group will be wearing the same wearable tech as the intervention group, but they will not receive any feedback about their activity level.

The feedback application will give participants in the intervention group information about the number of PAI they earn each week. PAI is short for personal activity Intelligence. You earn PAI points every time your heart rate increases: The higher heart rate, the faster you earn PAI. Previous research have shown that those who achieve 100 PAI or more every week over time live for an average of more than eight years longer than others.

During the study all participants will take part in a traditional inpatient rehabilitation program. The program consist of two periods at the rehabilitation center with two weeks at home in-between. The study will take place during the two periods at the senter and the period at home. Time spent on physical activity and number of earned PAI's will be counted during the period at home.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date January 14, 2020
Est. primary completion date January 14, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- taking part in inpatient rehabilitation at Unicare Helefort Rehabilitation center for chronic pain.

Exclusion Criteria:

- not having a smartphone (will not be able to access the mobile application).

- using a wheelchair (the technology will be not able to measure activity correctly)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Wearable tech with feedback
An armwrist device measuring physical activity level. The user will receive information about their physical activity level through their smartphone.
Wearable tech without feedback
An armwrist device measuring physical activity level, no reporting back to the user.
Behavioral:
Rehabilitation program
traditional inpatient rehabilitation program.

Locations

Country Name City State
Norway Unicare Helsefort Rissa

Sponsors (1)

Lead Sponsor Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Activity level Time spent in moderate to vigorous physical activity (minutes per day) 2 weeks (time period at home between two stays at the rehabilitation center)
Primary Number of PAIs mean number of Personal Activity Intelligence (PAI) points achieved per week 2 weeks (time period at home between two stays at the rehabilitation center)
Primary Percentage achieving 100 PAIs per week Personal Activity Intelligence (PAI) 2 weeks (time period at home between two stays at the rehabilitation center)
Secondary oxygen uptake submaximal oxygen uptake measured by the Åstrand bicycle test (described in Textbook of work physiology by Astrand from 1986) 6 weeks (from inclusion to end of rehabilitation program)
Secondary Anxiety and depression symptoms HSCL-25 questionnaire 6 weeks (from inclusion to end of rehabilitation program)
Secondary Average pain Visual Analogue Scale (VAS). VAS is a straight horizontal line where the ends are defined as the extreme limits from the left (0-no pain) to the right (100-worst imaginable pain). The patient is asked to mark his pain level on the line between the two endpoints. The distance between 'no pain at all' and the mark then defines the subject's pain. 6 weeks (from inclusion to end of rehabilitation program)
Secondary Health related quality of life EQ5D questionnaire 6 weeks (from inclusion to end of rehabilitation program)
Secondary Body weight body weight in kilograms 6 weeks (from inclusion to end of rehabilitation program)
Secondary Body Mass Index score weight in kilograms divided by height in metres squared 6 weeks (from inclusion to end of rehabilitation program)
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain